Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 33.55%
March 31, 2026 31.54%
December 31, 2025 29.25%
September 30, 2025 33.09%
June 30, 2025 34.45%
March 31, 2025 35.39%
December 31, 2024 35.74%
September 30, 2024 36.31%
June 30, 2024 36.60%
March 31, 2024 36.59%
December 31, 2023 38.77%
September 30, 2023 38.82%
June 30, 2023 35.82%
March 31, 2023 35.70%
December 31, 2022 41.36%
September 30, 2022 37.02%
June 30, 2022 36.39%
March 31, 2022 38.33%
December 31, 2021 41.15%
September 30, 2021 41.75%
June 30, 2021 40.38%
March 31, 2021 39.92%
December 31, 2020 38.57%
September 30, 2020 40.48%
June 30, 2020 39.07%
Date Value
March 31, 2020 42.18%
December 31, 2019 43.83%
September 30, 2019 43.70%
June 30, 2019 42.52%
March 31, 2019 41.85%
December 31, 2018 42.53%
September 30, 2018 46.50%
June 30, 2018 44.12%
March 31, 2018 42.40%
December 31, 2017 44.41%
September 30, 2017 42.45%
June 30, 2017 44.11%
March 31, 2017 42.67%
December 31, 2016 42.61%
September 30, 2016 43.35%
June 30, 2016 42.20%
March 31, 2016 40.59%
December 31, 2015 41.07%
September 30, 2015 41.98%
June 30, 2015 40.77%
March 31, 2015 41.07%
December 31, 2014 43.60%
September 30, 2014 44.15%
June 30, 2014 47.80%
March 31, 2014 49.12%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
DexCom, Inc. 63.44%
Becton, Dickinson & Co. 46.46%
Abbott Laboratories 52.64%
Boston Scientific Corp. 66.50%
CONMED Corp. 55.12%

Gross Profit Margin (Quarterly) Related Metrics